Philippe Gallay
8PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 04, 2024
Cyclophilin D knockout significantly prevents HCC development in a streptozotocin-induced mouse model of diabetes-linked NASH.Winston T Stauffer, Michael Bobardt, Daren R Ure
|Mar 01, 2024
Mice lacking cyclophilin B, but not cyclophilin A, are protected from the development of NASH in a diet and chemical-induced model.Winston T Stauffer, Asha Z Goodman, Michael Bobardt
|May 20, 2021
The combination of the NS5A and cyclophilin inhibitors results in an additive anti-HCV inhibition in humanized mice without development of resistance.Michael Bobardt, Christina M Ramirez, Marc M Baum
|Aug 09, 2020
Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice.Michael Bobardt, Magnus Joakim Hansson, Patrick Mayo
|Jan 25, 2020
The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice.Michael Bobardt, Joseph Kuo, Udayan Chatterji
|Jun 11, 2019
The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice.Philippe Gallay, Daren Ure, Michael Bobardt
Pageof 2
